Relief from digital vasospasm by treatment with captopril and its complete inhibition by serine proteinase inhibitors in Raynaud's phenomenon.
D015059:1-Sarcosine-8-Isoleucine Angiotensin II / Q000494:pharmacology; D000328:Adult; D007611:Aprotinin / Q000494:pharmacology; D002216:Captopril / Q000037:antagonists & inhibitors / Q000627:therapeutic use*; D005260:Female; D005385:Fingers / Q000098:blood supply*; D016670:Gabexate; D006146:Guanidines / Q000494:pharmacology; D006801:Humans; D011392:Proline / Q000031:analogs & derivatives*; D011480:Protease Inhibitors; D011928:Raynaud Disease / Q000188:drug therapy*; D012039:Regional Blood Flow / Q000187:drug effects
D006146:Guanidines; D011480:Protease Inhibitors; D016670:Gabexate; D007611:Aprotinin; D015059:1-Sarcosine-8-Isoleucine Angiotensin II; D011392:Proline; D002216:Captopril